60
Participants
Start Date
September 30, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2028
Cabozantinib
All patients will be treated with cabozantinib at 60 mg once daily.
National Taiwan University Hospital, Taipei
Mackay Memorial Hospital, Taipei
Taichung Veterans General Hospital, Taichung
Chang-Gung Memorial Hospital, Kaohsiung, Kaohsiung City
China Medical University Hospital, Taichung
National Cheng-Kung University Hospital, Tainan City
Taipei Veterans General Hospital, Taipei
Tri-Service General Hospital, Taipei
Chang Gung Memorial Hospital (Lin-Kou),, Taoyuan District
National Taiwan University Hospital
OTHER
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
Tri-Service General Hospital
OTHER
Mackay Memorial Hospital
OTHER
Chang Gung Memorial Hospital
OTHER
China Medical University Hospital
OTHER
Taichung Veterans General Hospital
OTHER
National Cheng-Kung University Hospital
OTHER
National Health Research Institutes, Taiwan
OTHER